Anna Mae Diehl

68.4k total citations · 25 hit papers
407 papers, 51.5k citations indexed

About

Anna Mae Diehl is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Anna Mae Diehl has authored 407 papers receiving a total of 51.5k indexed citations (citations by other indexed papers that have themselves been cited), including 268 papers in Epidemiology, 166 papers in Hepatology and 121 papers in Molecular Biology. Recurrent topics in Anna Mae Diehl's work include Liver Disease Diagnosis and Treatment (256 papers), Liver physiology and pathology (104 papers) and Diet, Metabolism, and Disease (77 papers). Anna Mae Diehl is often cited by papers focused on Liver Disease Diagnosis and Treatment (256 papers), Liver physiology and pathology (104 papers) and Diet, Metabolism, and Disease (77 papers). Anna Mae Diehl collaborates with scholars based in United States, United Kingdom and Portugal. Anna Mae Diehl's co-authors include Jeanne M. Clark, Elizabeth M. Brunt, Joel E. Lavine, Arun J. Sanyal, Steve S. Choi, Naga Chalasani, Mariana Verdelho Machado, Manal F. Abdelmalek, Zobair M. Younossi and Frederick L. Brancati and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Anna Mae Diehl

401 papers receiving 50.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

2012 3.0k citations Naga Chalasani, Joel E. Lavine et al. Hepatology profile →
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

2010 2.5k citations Arun J. Sanyal, Naga Chalasani et al. profile →
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

2014 1.7k citations Brent A. Neuschwander‐Tetri, Rohit Loomba et al. profile →
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

2012 1.4k citations Naga Chalasani, Joel E. Lavine et al. profile →
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

2015 1.1k citations Cynthia D. Guy, Lawrence A. David et al. Hepatology profile →
The Prevalence and Etiology of Elevated Aminotransferase Levels in The United States

2003 1.1k citations Anna Mae Diehl et al. profile →
Leptin regulates proinflammatory immune responses

1998 986 citations Anna Mae Diehl et al. profile →
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

2017 909 citations Anna Mae Diehl et al. profile →
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis

2007 805 citations Anna Mae Diehl et al. Hepatology profile →
NAFLD, NASH and liver cancer

2013 768 citations Gregory Michelotti, Anna Mae Diehl et al. profile →
Nonalcoholic fatty liver disease

2002 766 citations Anna Mae Diehl et al. profile →
Cytokines in Alcoholic and Nonalcoholic Steatohepatitis

2000 765 citations Herbert Tilg, Anna Mae Diehl profile →
Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

2003 758 citations Anna Mae Diehl et al. Hepatology profile →
Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis

1997 675 citations Anna Mae Diehl et al. profile →
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease

2018 668 citations Manal F. Abdelmalek, Anna Mae Diehl et al. Journal of Hepatology profile →
Fructose consumption as a risk factor for non-alcoholic fatty liver disease

2008 637 citations Anna Mae Diehl, Manal F. Abdelmalek et al. Journal of Hepatology profile →
Increased Fructose Consumption Is Associated With Fibrosis Severity in Patients With Nonalcoholic Fatty Liver Disease

2010 581 citations Manal F. Abdelmalek, Ayako Suzuki et al. Hepatology profile →
Metformin reverses fatty liver disease in obese, leptin-deficient mice

2000 564 citations Anna Mae Diehl et al. profile →
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial

2017 435 citations Rohit Loomba, Anna Mae Diehl et al. Hepatology profile →
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

2012 429 citations Naga Chalasani, Joel E. Lavine et al. profile →
Pathogenesis of Nonalcoholic Steatohepatitis

2016 401 citations Anna Mae Diehl et al. profile →
Alcohollike liver disease in nonalcoholics

1988 382 citations Anna Mae Diehl et al. profile →
Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease

2015 292 citations Gregory Michelotti, Guanhua Xie et al. PLoS ONE profile →
Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease

2019 270 citations Laura Wilson, Cynthia D. Guy et al. profile →
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials

2019 255 citations Arun J. Sanyal, Manal F. Abdelmalek et al. Hepatology profile →

Peers

Countries citing papers authored by Anna Mae Diehl

Since Specialization

Citations

This map shows the geographic impact of Anna Mae Diehl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Mae Diehl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Mae Diehl more than expected).

Fields of papers citing papers by Anna Mae Diehl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Mae Diehl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Mae Diehl. The network helps show where Anna Mae Diehl may publish in the future.

Co-authorship network of co-authors of Anna Mae Diehl

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Mae Diehl. A scholar is included among the top collaborators of Anna Mae Diehl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Mae Diehl. Anna Mae Diehl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cellular senescence in liver diseases: From molecular drivers to therapeutic targeting 2025 ·Journal of Hepatology ·Kuo Du, David S. Umbaugh, Nanqi Ren, Anna Mae Diehl	1
2	Redefining senescence through hepatocyte fate changes in liver diseases 2025 ·Trends in Endocrinology and Metabolism ·David S. Umbaugh, Anna Mae Diehl, Kuo Du	2
3	A humanized mouse model for adeno-associated viral gene therapy 2024 ·Nature Communications ·Mercedes Barzi, Tong Chen, (unknown), (unknown), (unknown), (unknown), (unknown), Yunhan Ma, (unknown), Sarah E. Woodfield, Anna Mae Diehl, Sanjeev A. Vasudevan, Nhu Thao Nguyen Galván, John A. Goss, Charles A. Gersbach, Beatrice Bissig-Choisat, Aravind Asokan, Karl‐Dimiter Bissig	7
4	Aging promotes metabolic dysfunction-associated steatotic liver disease by inducing ferroptotic stress 2024 ·Nature Aging ·Kuo Du, Liuyang Wang, Ji Hye Jun, Rajesh Kumar Dutta, Raquel Maeso‐Díaz, (unknown), Dennis C. Ko, Anna Mae Diehl	31
5	PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease 2024 ·Hepatology ·Naga Chalasani, Eduardo Vilar‐Gómez, Rohit Loomba, Katherine P. Yates, Anna Mae Diehl, Brent A. Neuschwander‐Tetri, Srinivasan Dasarathy, Kris V. Kowdley, Norah A. Terrault, Laura Wilson, James Tonascia, Arun J. Sanyal	18
6	Alterations in zonal distribution and plasma membrane localization of hepatocyte bile acid transporters in patients with NAFLD 2024 ·Hepatology Communications ·William A. Murphy, Anna Mae Diehl, Matthew Shane Loop, Dong Fu, Cynthia D. Guy, Manal F. Abdelmalek, Georgia Sofia Karachaliou, Noora Sjöstedt, Sibylle Neuhoff, Paavo Honkakoski, Kim L. R. Brouwer	7
7	Targeting senescent hepatocytes using the thrombomodulin-PAR1 inhibitor vorapaxar ameliorates NAFLD progression 2023 ·Hepatology ·Raquel Maeso‐Díaz, Kuo Du, Christopher C. Pan, Cynthia D. Guy, (unknown), (unknown), Liuyang Wang, Dennis C. Ko, Linda Tang, Rajesh Kumar Dutta, Ji Hye Jun, Ayako Suzuki, Manal F. Abdelmalek, Xiao‐Fan Wang, Anna Mae Diehl	19
8	Serum Metabolites Are Associated With HFpEF in Biopsy‐Proven Nonalcoholic Fatty Liver Disease 2023 ·Journal of the American Heart Association ·Kara Wegermann, Marat Fudim, Ricardo Henao, (unknown), Robert W. McGarrah, Cynthia D. Guy, Manal F. Abdelmalek, Anna Mae Diehl, Cynthia A. Moylan	5
9	Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis 2023 ·Hepatology ·Kuo Du, Raquel Maeso‐Díaz, (unknown), Ergang Wang, (unknown), Christopher S. Pan, Kun Xiang, Rajesh Kumar Dutta, Xiao‐Fan Wang, Jen‐Tsan Chi, Anna Mae Diehl	60
10	Spermidine-mediated hypusination of translation factor EIF5A improves mitochondrial fatty acid oxidation and prevents non-alcoholic steatohepatitis progression 2022 ·Nature Communications ·Jin Zhou, (unknown), Madhulika Tripathi, Jia Pei Ho, Anissa A. Widjaja, Shamini G. Shekeran, Stuart A. Cook, Ayako Suzuki, Anna Mae Diehl, Enrico Petretto, Brijesh Kumar Singh, Paul M. Yen	55
11	Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality 2020 ·PLoS ONE ·(unknown), Sendhilnathan Ramalingam, Mohammad Rauf Chaudhry, Yi Ren, Sin‐Ho Jung, Kristi Romero, Kelly Corbet, Nelson J. Chao, Taewoong Choi, Anna Mae Diehl, Louis F. Diehl, Cristina Gasparetto, Mitchell E. Horwitz, Gwynn D. Long, Richard D. Lopez, David A. Rizzieri, Stefanie Sarantopoulos, Keith M. Sullivan, Mustafa R. Bashir, Anthony D. Sung	4
12	Why we need to curb the emerging worldwide epidemic of nonalcoholic fatty liver disease 2019 ·Nature Metabolism ·Anna Mae Diehl, Nathalie J. Farpour‐Lambert, Liping Zhao, Herbert Tilg	18
13	Microbial nitrogen limitation in the mammalian large intestine 2018 ·Nature Microbiology ·Aspen T. Reese, Fátima C. Pereira, Arno Schintlmeister, David Berry, Michael Wagner, Laura P. Hale, Anchi Wu, Sharon Jiang, Heather K. Durand, (unknown), Richard T. Premont, Anna Mae Diehl, Thomas M. O’Connell, Susan C. Alberts, Tyler R. Kartzinel, Robert M. Pringle, Robert R. Dunn, Justin P. Wright, Lawrence A. David	92
14	Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis 2018 ·Science Translational Medicine ·Changyu Zhu, KyeongJin Kim, Xiaobo Wang, Alberto Bartolomé, Marcela Salomao, Paola Dongiovanni, Marica Meroni, Mark J. Graham, Katherine P. Yates, Anna Mae Diehl, Robert F. Schwabe, Ira Tabas, Luca Valenti, Joel E. Lavine, Utpal B. Pajvani	194
15	Thymosin beta-4 regulates activation of hepatic stellate cells via hedgehog signaling 2017 ·Scientific Reports ·Jieun Kim, Jeongeun Hyun, Sihyung Wang, Chanbin Lee, Jae‐Wook Lee, Eun‐Yi Moon, Hee‐Jae Cha, Anna Mae Diehl, Youngmi Jung	22
16	Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes 2016 ·Cancer Research ·Geoffrey J. Markowitz, Pengyuan Yang, Jing Fu, Gregory Michelotti, Rui Chen, Jianhua Sui, Bin Yang, Wenhao Qin, Zheng Zhang, Fu‐Sheng Wang, Anna Mae Diehl, Qi-Jing Li, Hongyang Wang, Xiaofan Wang	42
17	Paracrine Hedgehog Signaling Drives Metabolic Changes in Hepatocellular Carcinoma 2012 ·Cancer Research ·Isaac S. Chan, Cynthia D. Guy, Yuping Chen, Jiuyi Lü, Marzena Swiderska‐Syn, Gregory A. Michelotti, Gamze Karaca, Guanhua Xie, Leandi Krüger, Wing‐Kin Syn, (unknown), Thiago A. Pereira, Steve S. Choi, Albert S. Baldwin, Anna Mae Diehl	41
18	Hedgehog signalling regulates liver sinusoidal endothelial cell capillarisation 2012 ·Gut ·Guanhua Xie, Steve S. Choi, Wing‐Kin Syn, Gregory A. Michelotti, Marzena Swiderska, Gamze Karaca, Isaac S. Chan, Yuping Chen, Anna Mae Diehl	103
19	Hedgehog Signaling Blockade Delays Hepatocarcinogenesis Induced by Hepatitis B Virus X Protein 2012 ·Cancer Research ·Alla Arzumanyan, Vaishnavi Sambandam, Marcia M. Clayton, Steve S. Choi, Guanhua Xie, Anna Mae Diehl, Dae‐Yeul Yu, Mark A. Feitelson	58
20	Recruitment of host progenitor cells in rat liver transplants # 2008 ·Hepatology ·Zhaoli Sun, Xiuying Zhang, Jayme E. Locke, Qizhi Zheng, Shingo Tachibana, Anna Mae Diehl, George M. Williams	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact